Slingshot Insights | Cmpx Overview

CMPX Overview

Upcoming Projects (CMPX)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (CMPX)

Examining the Phase 2/3 COMPANION-002 trial results for Tovecimig (CTX-009) in second-line Biliary Tract Cancer from Compass Therapeutics
Tickers: CMPX, MRK, AZN, RHHBY, INCY, NVS
Executed On: Apr 29, 2026 at 01:00 PM EDT
Discussing treatment options for Biliary Tract Cancer (BTC) and the potential of CTX-009, a bispecific antibody targeting DLL4 and VEGF A, in combination with paclitaxel in patients with advanced BTC
Ticker: CMPX
Executed On: Apr 29, 2024 at 03:00 PM EDT

Upcoming & Overdue Catalysts (CMPX)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (CMPX)

Don’t see a strategic initiative related to the company you care about? Create your own!